Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP)
Cosmas Rinaldi Adithya Lesmana,Yoppi Kencana,Ikhwan Rinaldi,Juferdy Kurniawan,Irsan Hasan,Andri Sanityoso Sulaiman,Rino Alvani Gani
DOI: https://doi.org/10.2147/DMSO.S330526
2022-01-06
Abstract:Cosmas Rinaldi Adithya Lesmana, 1, 2 Yoppi Kencana, 1 Ikhwan Rinaldi, 3 Juferdy Kurniawan, 1 Irsan Hasan, 1 Andri Sanityoso Sulaiman, 1 Rino Alvani Gani 1 1 Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia; 2 Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta, Indonesia; 3 Department of Internal Medicine, Haematology and Oncology Division, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia Correspondence: Cosmas Rinaldi Adithya Lesmana Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jalan Diponegoro No. 71, Jakarta, Indonesia Email Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic inflammatory disease with excessive fat accumulation in the liver. Transient elastography (TE) with controlled attenuation parameter (CAP) is a device and method to examine the degree of fibrosis and steatosis. However, this device is not widely available across Indonesia. Neutrophil and lymphocyte ratio (NLR) is a simple marker for inflammation, which has a potency to predict disease outcome. This study aims to know the diagnostic value of NLR as the indicator of steatosis and fibrosis severity. Methods: This was a cross-sectional study with consecutive sample collection. We used secondary data from medical records, starting from 2016 to 2018. A descriptive and data analysis, including correlation test, multivariate linear regression, t -test, receiver operating curve (ROC) and area under the curve (AUC) were done to find out the outcome of the study. Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) Version 20.0 (SPSS Inc, Chicago, Illinois). A P value < 0.05 was considered as statistically significant. Results: Out of 106 subjects, 62.3% patients were women with the mean of age 57.29 years old and 77.4% had metabolic syndrome. Most patients had moderate to severe steatosis degree (66%) with the mean of TE mean 6.14 (2.8– 18.2) kPa. There was a positive correlation between CAP and TE compared with NLR with r = 0.648 (p < 0.001) and r = 0.621 (p < 0.001), respectively. The use of RNL to assess moderate-severe steatosis has a cutoff point of 1.775 with sensitivity, specificity, PPV and NPV, respectively, at 81.5%, 80.6%, 89.1%, and 69.1%; cutoff point 2.150 to assess significant fibrosis with sensitivity, specificity, PPV and NPV of 92.3%, 87.5%, 70.6%, and 97.2%, respectively. Conclusion: NLR has a positive and significant correlation with the degree of steatosis and fibrosis with high sensitivity and specificity as evaluated by TE/CAP. Keywords: neutrophil and lymphocyte ratio, steatosis, fibrosis, non-alcoholic fatty liver disease Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excessive accumulation of fat in the liver. 1,2 Its prevalence is increasing worldwide by around 20%, with 3–5% progress to NASH (Non-alcoholic Steatohepatitis). 1 In Asia, the prevalence of NAFLD was reported at 13% in 1990, which later became 30% in 2008. 3 NAFLD prevalence in Indonesia, which represents the biggest Southeast Asian country, was reported to be 30% in 2002 and later it increased until 51% in 2015. 4,5 NAFLD presentations have a broad spectrum, ranging from simple steatosis (NAFL) to advance liver disease, where 5–8% will then become liver cirrhosis in 5 years, then 12.8% of cirrhosis patients will further develop hepatocellular carcinoma (HCC) within 3 years. 6 Currently, NAFLD is considered to be the third most frequent cause of HCC in the United States, and liver transplantation due to cirrhosis associated with NASH is the second most common cause of transplantation in the United States, and is expected to be the most common cause of transplantation in the future. 2 The old paradigm considers NAFL to be a benign condition, the tendency to develop into cirrhosis and HCC development was considered very low. 2 Nevertheless, we cannot underestimate NAFL. 7,8 In general, this disease is closely related to the metabolic syndrome and its components. 9–11 At least one component of metabolic syndrome is owned by 90% of individuals with NAFLD, and 33% of NAFLD have all components of the metabolic syndrome. 11 Liver biopsy is still considered the gold standard for diagnosing NASH, but this procedure is less preferred because of its possible complications, such as bleeding and even death (1: 10.000). -Abstract Truncated-